Table 2.
Clinical and biological characteristics of 121 patients with chronic hepatitis C infection according to CD14 –159 genotypes (TT vs CC and CT)
| Clinical and biological characteristics | All patients |
CD14 –159 genotype |
|
| TT | CC or CT | ||
| Age (yr; mean±SD) | 37.2±11.5 | 38.0±12.3 | 37.1±11.4 |
| Male gender (%) | 66.1 | 58.6 | 68.5 |
| HCV transmission route (%) | |||
| - i.v. drug use | 25.6 | 24.1 | 26.1 |
| - Post-transfusion | 15.7 | 17.2 | 15.2 |
| - Other factors or unknown | 58.7 | 58.6 | 58.7 |
| HCV genotypes (%) | |||
| - Type 1 | 64.5 | 58.7 | 66.3 |
| - Type 3 | 27.3 | 34.5 | 25 |
| - Others than type 1 or 3 | 8.3 | 6.9 | 8.7 |
| Viral load | |||
| (106 copies/mL; median) | 1.7 | 2 | 1.6 |
| Initial virological response to anti-HCV treatment1 (%) | 65.9 | 66.7 | 65.7 |
1
HCV-RNA negative, 3 mo after the start of antiviral therapy; data available from 91/121 patients.